Your browser is no longer supported. Please, upgrade your browser.
ARYA Sciences Acquisition Corp IV
Index- P/E- EPS (ttm)- Insider Own3.23% Shs Outstand19.19M Perf Week1.12%
Market Cap190.75M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float14.95M Perf Month-0.70%
Income- PEG- EPS next Q- Inst Own88.50% Short Float0.04% Perf Quarter-5.15%
Sales- P/S- EPS this Y- Inst Trans-3.69% Short Ratio0.47 Perf Half Y-9.47%
Book/sh7.58 P/B1.31 EPS next Y- ROA- Target Price- Perf Year-
Cash/sh0.04 P/C238.44 EPS next 5Y- ROE- 52W Range9.73 - 12.38 Perf YTD-10.69%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-19.71% Beta-
Dividend %- Quick Ratio7.00 Sales past 5Y- Gross Margin- 52W Low2.16% ATR0.10
Employees- Current Ratio7.00 Sales Q/Q- Oper. Margin- RSI (14)47.93 Volatility0.52% 1.03%
OptionableNo Debt/Eq0.00 EPS Q/Q- Profit Margin- Rel Volume0.18 Prev Close9.95
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume11.65K Price9.94
Recom- SMA200.48% SMA50-1.78% SMA200-5.19% Volume2,109 Change-0.10%
ARYA Sciences Acquisition Corp IV focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 2020 and is based in New York, New York.